Research progress on the treatment of bullous pemphigoid with Dupilumab

In recent years, there have been many reports on the use of Dupilumab in the treatment of bullous pemphigoid. Dupilumab specifically binds to the subunit alpha of interleukin 4 receptor (IL-4Rα), blocking the signal transduction of interleukin (IL)-4 and IL-13, inhibiting the proliferation of B cell...

Full description

Bibliographic Details
Published in:Pifu-xingbing zhenliaoxue zazhi
Main Authors: LUO Xiaojia, JIANG Fuqiong, ZHANG Yaozhong, GAO Jian
Format: Article
Language:Chinese
Published: editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology 2024-08-01
Subjects:
bullous pemphigoid
treatment
dupilumab
Online Access:http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.08.010

Internet

http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.08.010

Similar Items